CABT-BL8420

antibody from Creative Diagnostics
Targeting: FLT4 PCL, VEGFR-3, VEGFR3
Provider product page for CABT-BL8420
Flow cytometry

Antibody data

Product number
CABT-BL8420 - Provider product page
Provider
Creative Diagnostics
Product name
Anti-VEGFA Monoclonal antibody, clone BGM5 [Biotin]
Antibody type
Monoclonal
Description
Vascular endothelial growth factor is a key regulator of blood vessel development in embryos and angiogenesis in adult tissues. Unlike VEGF, the related VEGFC stimulates the growth of lymphatic vessels through its specificl ymphatic endothelial receptor VEGFR-3. In 1998, Dumont showed that targeted inactivation of the VEGFR-3 gene in mice resulted in defective blood vessel development in early embryos. Vasculogenesis and angiogenesis occurred, but large vessels became abnormally organized with defective lumens, leading to fluid accumulation in the pericardial cavity and cardiovascular failure at embryonic day 9.5. Thus, VEGFR3 has an essential role in the development of theembryonic cardiovascular system before the emergence of the lymphatic vessels.
Reactivity
Mouse
Host
Rat
Conjugate
Biotin
Isotype
IgG
FLT4 protein structure - CABT-BL8420 shown in red.